Natural killer lymphocytes: biology, development, and function.
about
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assaySublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.Defining early human NK cell developmental stages in primary and secondary lymphoid tissuesImmune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.Angiogenesis and antiangiogenic agents in cervical cancer.IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.Variable contribution of monoclonal antibodies to ADCC in patients with chronic lymphocytic leukemia.Ageing is associated with a decline in peripheral blood CD56bright NK cells.Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathwayTumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.Immune restoration following hematopoietic stem cell transplantation: an evolving target.Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer.Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma.Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivoCharacterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas.Current status of bevacizumab in advanced ovarian cancerImmunobiology of human cytomegalovirus: from bench to bedside.Aiming to immune elimination of ovarian cancer stem cellsCD8 T Cells in old mice contribute to the innate immune response to Mycobacterium tuberculosis via interleukin-12p70-dependent and antigen-independent production of gamma interferon.Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.p38 MAPK Signaling in Pemphigus: Implications for Skin AutoimmunityClinical evaluation of systemic and local immune responses in cancer: time for integration.Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.Investigation on Immunomodulatory Activity of Calf Spleen Extractive Injection in Cyclophosphamide-induced Immunosuppressed Mice and Underlying Mechanisms.Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.Selective expansion of human natural killer cells leads to enhanced alloreactivityHuman IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+ progenitor cells.Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients.The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells.Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer.Interferon-gamma secretion is induced in IL-12 stimulated human NK cells by recognition of Helicobacter pylori or TLR2 ligands
P2860
Q24800129-507D19F5-3E7A-41AE-B7D8-F50C473109C5Q31153121-BF8248A9-6C43-4070-A3E7-980E0308A490Q34154688-1D45C77D-406D-41ED-9DFF-FF78C3F713EFQ34557233-86080F4B-D074-4476-AAA5-7A15F28A4893Q34655335-D1C956A3-4C03-4D7A-B3C5-0178CAD51EEDQ34707156-269A7ABB-30C6-4D0C-81BA-3360F3CB91D1Q34989602-B4944A22-77F3-4039-BAD0-23A33FD60485Q35225681-B948B607-AA27-4326-95ED-C81D95E21A49Q35787150-082CDE4F-B41B-419C-ACB1-5CA766732029Q35906013-60AD0A6D-465B-42C0-9CDC-B1C53A530D54Q36075296-DD61F5F3-3675-4F0D-8A91-D18F62778354Q36150511-853DD233-58E6-4B9D-A6CF-3F657B58B204Q36244004-BF8E8A6E-EE22-4B49-8ECA-25A32CE3DA86Q36763133-D2152932-F893-4655-939C-4D4F1BF14451Q36984489-2C117977-5D3D-42EF-88A3-87E1D942D734Q37048186-A23BEA6A-021C-4E92-884F-5C0D4320F51DQ37050965-355BD3DC-479C-41DB-83E4-AED6745D23A7Q37266548-D4A1CF71-A473-42B4-A56D-A1A38EDE6AE4Q37274811-107D35D6-D4E8-4312-ACBD-4FD6225B40EDQ37763996-F5B7ED8D-558E-4C50-9B61-0A4108F39A54Q38128304-EED42D2B-4749-4E2A-8D49-D090ADED3947Q38150174-3DD1BE78-9BB8-4647-962C-18C160363D4DQ38151193-0856530B-2D6D-4466-84BD-47015E6AF080Q38776283-D32D0CDA-BDA7-4963-91BA-738361EC9760Q38906557-D69F2A1D-1F69-4318-BE1B-384BD5C848D7Q39029073-15AA8DD2-0338-43BA-BE03-D4821AE3AD75Q39331127-5D246118-E93F-4864-95CC-2552D3589364Q39476610-50BCF355-7FAE-47FD-9C79-50D6E9DA2489Q41220323-C08988DB-984E-42DA-9C47-32100E0A39C8Q42317995-64AFBCCF-242C-4F45-8A06-CBF4157A12CFQ46940975-46593D9E-1F15-4932-9681-15AE5B379F92Q47564469-CBE5B319-C59B-45E0-A616-05F92451F7F3Q50145104-08B918BE-16D1-4570-8134-5C7291410048Q58283211-A166B9C2-5E7A-440C-9B00-60584613E3AA
P2860
Natural killer lymphocytes: biology, development, and function.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Natural killer lymphocytes: biology, development, and function.
@ast
Natural killer lymphocytes: biology, development, and function.
@en
type
label
Natural killer lymphocytes: biology, development, and function.
@ast
Natural killer lymphocytes: biology, development, and function.
@en
prefLabel
Natural killer lymphocytes: biology, development, and function.
@ast
Natural killer lymphocytes: biology, development, and function.
@en
P2093
P1476
Natural killer lymphocytes: biology, development, and function.
@en
P2093
Angelos D Gritzapis
Constantin N Baxevanis
Michael Papamichail
Sonia A Perez
P2888
P304
P356
10.1007/S00262-003-0478-4
P577
2003-12-18T00:00:00Z